Skip to main content

The Case for Greater Diversity in Research

Dr. Boden-Albala describes why involvement of diverse populations is critical to clinical trials, why inclusion remains suboptimal, and what we can do about it in this piece in Neuron, “Confronting legacies of underrepresentation in clinical trials: The case for greater diversity in research.”